Immunizing children to protect against the increasing risk of hepatitis A in adolescents and young adults in South Korea.
Southeast Asian J Trop Med Public Health
; 35(4): 954-8, 2004 Dec.
Article
en En
| MEDLINE
| ID: mdl-15916097
We evaluated the CR326F strain (VAQTA) derived hepatitis A vaccine in Korean children and adolescents >2 years of age to consider a future immunization program. In our study, the pediatric two-dose regimen of VAQTA was found to be generally well tolerated and resulted in 100% (95% CI 94.8, 100.0) seroconversion after 2 doses. Immunizing children with the HAV vaccine routinely should be considered in South Korea, particularly in areas where recent outbreaks have occurred.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Brotes de Enfermedades
/
Vacunas contra la Hepatitis A
/
Hepatitis A
Tipo de estudio:
Etiology_studies
/
Risk_factors_studies
Límite:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Female
/
Humans
/
Male
País/Región como asunto:
Asia
Idioma:
En
Revista:
Southeast Asian J Trop Med Public Health
Año:
2004
Tipo del documento:
Article
Pais de publicación:
Tailandia